- Home
- IXHL vs LIPO Comparison
IXHL vs LIPO Comparison
Compare IXHL & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- LIPO
- Stock Information
- Founded
- IXHL 2001
- LIPO 2005
- Country
- IXHL Australia
- LIPO United States
- Employees
- IXHL N/A
- LIPO N/A
- Industry
- IXHL
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- IXHL
- LIPO Health Care
- Exchange
- IXHL Nasdaq
- LIPO Nasdaq
- Market Cap
- IXHL 3.6M
- LIPO 3.1M
- IPO Year
- IXHL N/A
- LIPO 2022
- Fundamental
- Price
- IXHL $0.18
- LIPO $2.99
- Analyst Decision
- IXHL
- LIPO
- Analyst Count
- IXHL 0
- LIPO 0
- Target Price
- IXHL N/A
- LIPO N/A
- AVG Volume (30 Days)
- IXHL 146.9M
- LIPO 39.2K
- Earning Date
- IXHL 05-15-2025
- LIPO 05-14-2025
- Dividend Yield
- IXHL N/A
- LIPO N/A
- EPS Growth
- IXHL N/A
- LIPO N/A
- EPS
- IXHL N/A
- LIPO N/A
- Revenue
- IXHL $98,000.00
- LIPO $519,866.00
- Revenue This Year
- IXHL $3,817.06
- LIPO N/A
- Revenue Next Year
- IXHL $66.67
- LIPO N/A
- P/E Ratio
- IXHL N/A
- LIPO N/A
- Revenue Growth
- IXHL N/A
- LIPO 8.88
- 52 Week Low
- IXHL $0.08
- LIPO $1.97
- 52 Week High
- IXHL $3.55
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- IXHL 42.72
- LIPO 58.50
- Support Level
- IXHL $0.18
- LIPO $2.75
- Resistance Level
- IXHL $0.21
- LIPO $3.17
- Average True Range (ATR)
- IXHL 0.03
- LIPO 0.29
- MACD
- IXHL 0.01
- LIPO 0.02
- Stochastic Oscillator
- IXHL 6.64
- LIPO 81.05
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.